Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Financially Fit Penny Stocks

Hong Kong Pharmaceuticals & Biotech Financially Fit Penny Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses

26 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
2005 SSY Group	HK$3.32	1.2%	-25.7%	HK$9.8b	HK$5.74	PE7.2x	E6.6%	5.4%
239 Pak Fah Yeow International	HK$2.50	0.8%	38.9%	HK$779.1m	n/a	PE8.1x	n/a	8.6%
2348 Dawnrays Pharmaceutical (Holdings)	HK$1.20	0%	-1.6%	HK$1.8b	n/a	PE3x	n/a	6.4%
1177 Sino Biopharmaceutical	HK$3.34	3.4%	6.4%	HK$60.7b	HK$4.49	PE26.5x	E12.6%	1.7%
2161 JBM (Healthcare)	HK$1.80	1.1%	87.5%	HK$1.5b	n/a	PE8.9x	n/a	6.1%
512 Grand Pharmaceutical Group	HK$4.80	4.6%	31.5%	HK$16.8b	HK$6.63	PE7x	E2.3%	5.4%
690 Uni-Bio Science Group	HK$0.056	7.7%	-34.9%	HK$334.4m	n/a	PE3.4x	n/a	n/a
6628 Transcenta Holding	HK$0.89	27.1%	-61.6%	HK$359.8m	HK$9.11	PS15x	E11.6%	n/a
1477 Ocumension Therapeutics	HK$4.59	9.5%	-11.0%	HK$3.7b	HK$8.35	PS11.3x	E97.2%	n/a
8049 Jilin Province Huinan Changlong Bio-pharmacy	HK$1.47	-12.5%	-21.0%	HK$823.6m	n/a	PE4.5x	n/a	36.4%
1889 Sanai Health Industry Group	HK$0.33	-4.3%	-73.6%	HK$50.5m	n/a	PE3.6x	n/a	n/a
1666 Tong Ren Tang Technologies	HK$4.79	-0.6%	-13.1%	HK$6.1b	HK$6.44	PE8.8x	E-0.2%	4.0%
2126 JW (Cayman) Therapeutics	HK$2.41	40.9%	20.5%	HK$975.1m	HK$2.40	PS5.3x	E4.3%	n/a
950 Lee's Pharmaceutical Holdings	HK$1.27	-0.8%	-2.3%	HK$747.8m	n/a	PE11.9x	n/a	2.4%
9939 Kintor Pharmaceutical	HK$1.10	14.6%	-24.1%	HK$476.3m	n/a	PB1.1x	n/a	n/a
1521 Frontage Holdings	HK$1.43	-4.0%	-19.2%	HK$2.9b	HK$1.12	PE61.1x	E67.7%	n/a
8225 China Health Group	HK$0.17	-1.1%	22.7%	HK$172.2m	n/a	PS6.5x	n/a	n/a
2616 CStone Pharmaceuticals	HK$3.11	15.2%	93.2%	HK$4.0b	HK$2.51	PS8.1x	E49.9%	n/a
8158 China Regenerative Medicine International	HK$0.27	0%	-34.6%	HK$80.6m	n/a	PS1.5x	n/a	n/a
6996 Antengene	HK$2.05	83.0%	73.7%	HK$1.4b	HK$1.33	PS23.2x	E16.8%	n/a
2137 Brii Biosciences	HK$1.58	41.1%	-12.2%	HK$1.1b	HK$1.00	PS27.9x	E-7.4%	n/a
1244 3D Medicines	HK$3.09	3.3%	-51.3%	HK$757.2m	n/a	PS1.4x	n/a	n/a
1167 Jacobio Pharmaceuticals Group	HK$1.97	32.2%	-18.9%	HK$1.6b	HK$1.85	PS62.6x	S-2.6%	n/a
1349 Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd	HK$2.73	10.1%	17.2%	HK$7.1b	n/a	PE25.1x	n/a	1.6%

Page 1 of 2